ArticlePloS one2016

Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis.

O Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.